Nature’s Sunshine’s second quarter was met with a significant negative market reaction following results that missed Wall Street’s revenue and non-GAAP profit expectations. Management attributed the quarter’s growth to strong digital channel expansion, particularly in North America and Asia Pacific, and highlighted a 26% increase in digital sales. CEO Ken Romanzi pointed to ongoing investments in digital tools, consultant engagement, and new customer acquisition as key drivers, while acknowledging regional weakness, especially the unexpected slowdown in China.
Is now the time to buy NATR? Find out in our full research report (it’s free for active Edge members).
Nature's Sunshine (NATR) Q2 CY2026 Highlights:
- Revenue: $117 million vs analyst estimates of $123.7 million (1.9% year-on-year growth, 5.4% miss)
- Adjusted EPS: $0.21 vs analyst expectations of $0.27 (22.2% miss)
- Adjusted EBITDA: $11.33 million vs analyst estimates of $12.19 million (9.7% margin, 7.1% miss)
- The company dropped its revenue guidance for the full year to $495 million at the midpoint from $507.5 million, a 2.5% decrease
- EBITDA guidance for the full year is $50 million at the midpoint, below analyst estimates of $52.65 million
- Operating Margin: 4.7%, in line with the same quarter last year
- Market Capitalization: $272.9 million
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Nature's Sunshine’s Q2 Earnings Call
- Susan Anderson (Canaccord Genuity) asked for more detail on North America’s core business performance and the Germany market launch. CEO Ken Romanzi acknowledged ongoing softness in the direct selling channel but highlighted plans for a comprehensive relaunch and gradual ramp-up in Germany as strategic priorities.
- Susan Anderson (Canaccord Genuity) inquired about product and brand drivers across regions. Romanzi explained that Synergy’s core products and new skincare offerings are fueling growth in Asia, while gut health products remain the top sellers in North America.
- Susan Anderson (Canaccord Genuity) questioned M&A strategy and criteria. Romanzi stated the company is targeting supplement businesses that can be integrated into its supply chain, with a preference for diversification by channel and geography, but will be selective to ensure earnings accretion and operational fit.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will be closely monitoring (1) the pace of digital and social commerce adoption, especially the conversion of new customers into recurring subscription buyers; (2) the impact of operational recovery efforts in China and the early performance of the Germany market; and (3) the effectiveness of leadership transitions in accelerating North American direct selling growth. The launch trajectory of new product lines and the ability to mitigate foreign exchange headwinds remain additional key signposts.
Nature's Sunshine currently trades at $15.63, down from $20.34 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
